|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:MediNatura
Kraft_Foods'_pharmaceutical_division
|
|
gptkbp:businessModel
|
B2B
B2C
|
|
gptkbp:CEO
|
gptkb:Sandeep_Singh
Rakesh_Kumar
|
|
gptkbp:certifications
|
gptkb:ISO_9001
gptkb:US_FDA
gptkb:WHO_GMP
gptkb:TGA_Australia
|
|
gptkbp:clinicalTrials
|
Yes
|
|
gptkbp:employees
|
~10,000
|
|
gptkbp:focus
|
Cardiology
Gastroenterology
Oncology
Pain management
Respiratory diseases
Diabetes
Neurology
Infectious diseases
Pediatrics
Dermatology
Geriatrics
Oral health
Chronic diseases
Eye care
Women’s health
Vitamins and supplements
Lifestyle diseases
Men’s health
Acute diseases
|
|
gptkbp:founded
|
1973
|
|
gptkbp:founder
|
gptkb:Samant_Kumar_Choudhary
|
|
gptkbp:headquarters
|
gptkb:Mumbai,_India
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Alkem Laboratories
|
|
gptkbp:market
|
gptkb:India
gptkb:Southeast_Asia
gptkb:United_States
Africa
|
|
gptkbp:operationalStatus
|
gptkb:Ravi_Kumar
|
|
gptkbp:partnerships
|
Various healthcare organizations
|
|
gptkbp:products
|
Nutraceuticals
Over-the-counter medications
Generic_drugs
|
|
gptkbp:researchAndDevelopment
|
Yes
|
|
gptkbp:revenue
|
$1 billion (2020)
|
|
gptkbp:stockExchange
|
gptkb:BSE
NSE
|
|
gptkbp:subsidiary
|
gptkb:Alkem_Laboratories_(Canada)_Inc.
gptkb:Alkem_Laboratories_(UK)_Ltd.
Alkem Laboratories USA, Inc.
|
|
gptkbp:website
|
www.alkemlabs.com
|